Related references
Note: Only part of the references are listed.Genomic analysis of racial differences in triple negative breast cancer
Chang-Sheng Chang et al.
GENOMICS (2019)
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Diego Chowell et al.
SCIENCE (2018)
LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer
Masoud F. Tavazoie et al.
CELL (2018)
Racial disparity in breast cancer immune microenvironment.
Ahmed Elkhanany et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
Jason J. Pitt et al.
NATURE COMMUNICATIONS (2018)
Rejection of immunogenic tumor clones is limited by clonal fraction
Ron S. Gejman et al.
ELIFE (2018)
Bringing the Next Generation of Immuno-Oncology Biomarkers to the Clinic
Alessandra Cesano et al.
BIOMEDICINES (2018)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy
Mirjana Efremova et al.
FRONTIERS IN IMMUNOLOGY (2017)
Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer
Thomas Karn et al.
JAMA ONCOLOGY (2017)
Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas
Dezheng Huo et al.
JAMA ONCOLOGY (2017)
Immune Gene Expression Is Associated with Genomic Aberrations in Breast Cancer
Anton Safonov et al.
CANCER RESEARCH (2017)
Breast Cancer Statistics, 2015: Convergence of Incidence Rates Between Black and White Women
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Subtype-Specific Metagene-Based Prediction of Outcome after Neoadjuvant and Adjuvant Treatment in Breast Cancer
Maurizio Callari et al.
CLINICAL CANCER RESEARCH (2016)
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors
Sherene Loi et al.
CLINICAL CANCER RESEARCH (2016)
The genomic landscape of breast cancer and its interaction with host immunity
Stephen Luen et al.
BREAST (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis
Tingting Jiang et al.
PLOS MEDICINE (2016)
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Brian D. Lehmann et al.
PLOS ONE (2016)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Giovanni Ciriello et al.
CELL (2015)
The Influence of Host Factors on the Prognosis of Breast Cancer: Stroma and Immune Cell Components as Cancer Biomarkers
Thomas Karn et al.
CURRENT CANCER DRUG TARGETS (2015)
Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence
Tanya Keenan et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base
Brigid K. Killelea et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer
Hallie Wimberly et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Triple-negative breast cancer in African-American women: disparities versus biology
Eric C. Dietze et al.
NATURE REVIEWS CANCER (2015)
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
Scott D. Brown et al.
GENOME RESEARCH (2014)
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
Sylvia Adams et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Regulation of MHC Class I Expression by Foxp3 and Its Effect on Regulatory T Cell Function
Jie Mu et al.
JOURNAL OF IMMUNOLOGY (2014)
The cancer antigenome
Bianca Heemskerk et al.
EMBO JOURNAL (2013)
MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma
Edmund A. Mroz et al.
ORAL ONCOLOGY (2013)
Identification of genomic functional hotspots with copy number alteration in liver cancer
Tzu-Hung Hsiao et al.
EURASIP JOURNAL ON BIOINFORMATICS AND SYSTEMS BIOLOGY (2013)
Higher Parity and Shorter Breastfeeding Duration Association With Triple-Negative Phenotype of Breast Cancer
Shivani S. Shinde et al.
CANCER (2010)
African Ancestry and Higher Prevalence of Triple-Negative Breast Cancer Findings From an International Study
Azadeh Stark et al.
CANCER (2010)
Molecular Anatomy of Breast Cancer Stroma and Its Prognostic Value in Estrogen Receptor-Positive and -Negative Cancers
Giampaolo Bianchini et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
Carsten Denkert et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Differences in the Tumor Microenvironment between African-American and European-American Breast Cancer Patients
Damali N. Martin et al.
PLOS ONE (2009)
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
Achim Rody et al.
BREAST CANCER RESEARCH (2009)
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer
Francisco J. Esteva et al.
BREAST CANCER RESEARCH (2007)
The response of autologous T cells to a human melanoma is dominated by mutated neoantigens
V Lennerz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Share Paper
